clinical trials workshop & summit 2015
DESCRIPTION
Following our past four highly successful events, this event focuses on “A Critical Guide for Successfully Conducting “6th Annual Clinical Trials Summit 2015” It gives me great pleasure in welcoming all of you to The Virtue Insight’s “6th Annual Clinical Trials Summit 2015”. I wish and pray that all our efforts will be beneficial to our industries folks at large.Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to TEL: + 91 9171350244 or [email protected], [email protected]TRANSCRIPT
-
KEYSPEAKERSINCLUDE:-
K.Bangarurajan,Dy.DrugsController(I)CDSCO,
ArunBhatt,President,
BhaswatS.Chakraborty,SeniorVP,R&D,
AmitArora,HeadMedicalAffairs,
AshwaniPandita,HeadQualityManagementandTraining,GlobalClinicalResearch Operations,
KedarSuvarnapathaki,Head-RegulatoryAffairs,
ChiragTrivedi,Director&HeadofClinicalStudyUnit,
BabitaKirodian,HeadofCountryPharmacovigilance,
KavithaIyerRodrigues,Director,COO,
PratikShah,Head-Clinical,Medical&RegulatoryAffairs,PVandQA,
JyotsnaPatwardhar,HeadDevelopmentQA,
MazharMaruf,RegionalHeadofPharmacovigilance-AsiaPacific,
SujaySalvi,Head,ClinicalTrialSuppliesManagement,
ChitraBargaje,Consultant,
V.K.Sharma,AssociateVicePresident,
MilindAntani,Head-PharmaLifeSciences,
DeeptiSanghavi,SeniorMedicalWriter-MedicalWriting,
DCGI
ClininventResearch
Cadila
MerckSerono
Glenmark
BoehringerIngelheim
SanofiAventis
BristolMyersSquibb
TheramytNovobiologics
AstellasPharma
Novartis
Glenmark
SIROClinpharm
ADAMASConsulting
UnichemLaboratories
NishithDesaiAssociates
SIROClinpharm
PlusManyMore...
ConferenceHashtag-#VI_Pharma
-
ORGANIZEDBY
GOLDPARTNER
SUPPORTEDBY
ASSOCIATEPARTNER
WORKSHOPPARTNER
6thAnnualClinicalTrialsSummit2015
28th&29thMay2015,KohinoorContinentalHotel,Mumbai,India
-
CONFERENCEINTRODUCTION:-
TheInternationalRegistryofClinicaltrials,thedatabankmaintainedbytheNIHinU.S.(clinicaltrials.gov),hasaround203,394trialsbeingcarriedoutworldwide.As
perthisregistry,thenumberoftrialscarriedoutinIndiaisonly3043,whichis40%ofallglobaltrialsarecarriedoutintheU.S.Chinahasregistered17198trials(>8%),substantiallyhigherthanIndia.Thefearthatthereis
anavalancheoftrialsmovingouttoIndia,riskingourpopulationtotrialdrugsisthusunfounded.AsofnowIndiaisbynomeansapreferredhubforclinicaltrials,but
thethepotentialtobecomeone,inviewofmanyfavourablefactors,suchasstate-of-the-artskillsofinvestigators,levelofqualityhealthcareinstitutions,the
availabilityofpatientpopulationswithdiversegeneticpools,languageadvantageandinformationtechnologybasedanalyticaltools.
TheeventsofthelasttwoyearswhichseverelyaffectedtheclinicaltrialscenarioinIndiamayhaveevenconsolidatedandtightenedthesystemtobringinmore
transparencyandqualityassurancewhichwillenhancethecredibilityofIndianeffortsinthearea.Whatisrequiredisasystematic,timeboundregulatoryevaluation
andapprovalsystemforallphasesoftrialsandbetterandtransparentcommunicationbetweenthestakeholdersandtheregulatoryagency.Withoutnewdrugs
discovery,muchofthediseaseproblemsoftheworldwillremainunattendedandneglected.Thenewgovernment,inoneofitsearlypolicystatementshademphasized
theneedtoencourageproperlyconductedclinicaltrialsinIndiawithappropriateregulatorycontrols.Itisferventlyhopedthatrealisingtheimportanceofthissegment
inNewDrugDiscoveryResearch,theconcernedauthoritieswilltakeapragmaticviewandthroughtimeboundandmorediligentapprovalprocessesencourageclinical
research.
6thannualclinicaltrialssummit2015willexaminethecurrentissuesfacedinclinicaltrialsoperations,addressingtherisks,timelineandbudgetstipulations,while
effectivelytacklingkeychallengesinovercomingtrialsagreementandsitecontractarbitrationproblems.Thissummitwilldiscusstheoperationalelementoftrialsite
management,strategicpartnershipwithCROsandSMOs,patient,talent&investigatorsmanagementinordertoimprove&optimizetheoveralldrugdevelopment
effectivenessandROI.Thisconferencewillbesharedby leadingindustrialpractitionersacrosstheregiontopromotepracticaldiscussions;especiallyontheknow-how
tomanageneeds,variabilityofdifferentcountriesandinstitutionstoenhanceclinicaloperationalexcellenceandvigilance.Attendeeswillhavethechancetolearn,
networkandbenchmarkagainsttheglobaltoppharmasandlocalindustryleadersonthebestpracticesintalent,site,budgetandperformancemanagementinclinical
trials.TheconferenceaimstoprovideadetailedanalysisofwhatittakestoconductclinicaltrialsfromabiopharmaceuticalsandvaccinesperspectiveinIndiaandalso
addressingrisk/benefitbalance,anecdotalexperiencesofthemultinationalpharmaceuticalindustryinIndiaandotherpartsofAsia,selectionandroleofCROs,logistics
ofoperations,clinicaltrialsmanagement,governmentpoliciesandpharmacovigilance.6thannualclinicaltrialssummit2015willprovideyouwiththedatathatyou
needtorecognizethiscomplexandrapidlyexpandingsector.Knowingthefuturemarket,andwhatimpactswillthathasonfuturebusinessopportunities?Thisisyour
opportunitytostayaheadbylearningthelatesttrendsandnetworkingwiththetrendsetters.
Itgivesusimmensepleasureinwelcomingyoutothe .Iwishandpraythatalloureffortswillbebeneficialtoourindustries
andtoourcountryatlarge
6thAnnualClinicalTrialsSummit2015
Updateyourselfwithrespecttotermsoflegislation,policies,systems,technology,communicationstrategiesandbestpractices
Determiningthestepsandstrategiesforenhancingqualityinhealthcare
DiscoveringthenewtrendsinglobalclinicaltrialsandtheirroleinIndia
Technologiesthatdriveefficienciesinglobalclinicaltrials
StrategiestoconductsuccessfulinterventionaloncologytrialsinIndia
Qualitybydesign
Monitoring,managingandleadingclinicaltrials:Anintegratedapproachforbettertrialsuccess
Maintainingproperbalanceinrelationships:Sponsor Site CRO&Patients
Marginofsafety:IdentifyingidealclinicalsitesandstrategizingpatientrecruitmentandclinicalsitesmanagementinIndiatodevelopappropriateclinicalstudies
EffectivelyincorporatingGCP&GCPs KnowingwhatTO-DOandwhatNOTTO-DO
Re-Thinkingpatientrecruitmentandpatientexperience
FindingtheidealpartnerinoutsourcingyourlogisticsoperationsinIndiahowtoidentifysmartpackagingsolutionstobalancequalityandcosts
IdentifyingthedecisioncriteriaforpartneringwiththerightvendorsinAsia
Howtomanagerisksinclinicaltrialseffectivelyandhowtosuccessfullyincorporaterisksharingmodelsinclinicaltrials
Avoidingmistakesindatacollectionandensuringprofitabilityandtounderstandthelongtermoperationstrategiesformanagingclinicaltrials.
Overcomingchallengesfacedinregulatoryapprovalprocesses obtainingdrug/clinicalsuppliesimportandexportlicensesinAsia
RegulatoryreviewatthedrugscontrollergeneralofIndia(DCGI)andcentraldrugsstandardcontrolorganization(CDSCO):science,quality,andspeed
Analyzingtherecentgovernmentrulesandguidelines
Nextgenerationsofclinicaltrials Howbigwillthemarketbe?
Bepartofamajornetworkingopportunity
TARGETAUDIANCE-INDUSTRY:-
Pharmaceuticalorganisations,Genericpharmaceuticalcompanies,Contractresearchorganisations,Patientrecruitmentcompanies,Government-Departmentofhealth,
Non-profitorganisations/Association,Consultants
WHOSHOULDATTEND:-
CEO's,CTO's,CIO's,Presidents,VicePresidents,DirectorsHeads&Managersof: ClinicalResearch&Development,ClinicalResearchServices,ClinicalOperations,ClinicalDataManagement,ClinicalIT,ClinicalTrials,MedicalAffairs,RegulatoryAffairs,Compliance,Qualitycontrol/Assurance/GCP,ClinicalStudyDesign,
SafetySurveillance,SubjectRecruitment,E-ClinicalSystems.
WHYSHOULDYOUATTEND:-
Getmorefromtheevent,withabroaderscopebringing
thewholecommunicationsvaluechaintogether.Enjoyandmakethebestoutofourdedicatednetworkingdrinkstime,meettheleadinginternationalvendorsexpand
yourknowledgeofthelatestbusinessmodelsandstrategiesinthehigh-levelconference.Showcasingtheproductsoftomorrowintheco-locatedexhibition.
6thAnnualClinicalTrialsSummit2015- -Acriticalguideforsuccessfullyconductingclinicaltrials
KEYTHEMESDISCUSSEDATTHISSUMMIT:-
6thAnnualClinicalTrialsSummit2015
28th&29thMay2015,KohinoorContinentalHotel,Mumbai,India
-
08:30 Coffeeandregistration
09:30 Chairpersonopeningremarks
09:40 IndianClinicalTrials:Currentchallengesandfuturefocus
10:10 Clinicaltrialoutsourcing:Concernsandguidelines
Anopportunitytomeetandto
networkwithyourconferencecolleagues.
EvolvingIndianRegulatoryscenario
ChallengestoIndia'spotentialinclinicalresearch
Focussingthefutureonfundamentals
StatusofIndiaincurrentglobalclinicalresearchmarket
ConductingclinicaltrialsinIndia
Latestguidelines&scrutinizingforinvestigators
PossibleremediesforIndianmarkettomatchregulatory
guidelines
industry
10:40 MorningCoffee/Tea&Discussion
V.K.Sharma,AssociateVicePresident,
ArunBhatt,President,
UnichemLaboratories
ClininventResearch
(https://www.linkedin.com/pub/v-k-sharma/23/ba/197)
MorningKeynoteAddress1:
MorningKeynoteAddress2:
(https://www.linkedin.com/pub/arun-bhatt-dr/4/9bb/658)
HowtoimprovequalityassuranceinIndianclinicalresearch
11:40 Riskbasedapproach
12:10 ClinicalResearchinPractice
Onsiteandremotemonitoringapproaches
Recurrentrisksandmitigationthroughmonitoring
Quality-by-design
Riskmanagementandriskminimization
Riskminimizationeffectivenessmeasurement
Clinicaldevelopmentandoperations
InIndiaforIndia,Asiaandtheworldcomparativeeffectiveness
research
Integratevariousclinicaltrialsystemstoimprovedataquality
GCPandGCRP
11:00 KeynotePanelDiscussion:ChallengesandOpportunitiesfornowandfuture
Moderator:
Panellists:
Whatarethecurrentproblemsfacedintodaysmarketandhowto
successfullyovercometheminthishighlycompetitivemarket?
Whichemergingmarketsarehottesttoday?
Offshoring-Balancingtherightopportunitiesandrisks
Whatmakeseachmarketuniqueandhowdomarketscompare?
Successfulbudgetdevelopment&analysis-Howdosponsors
developstudybudgets?Howdositespricetheirservices?
Recruitmentandretentionofpatients
V.K.Sharma,AssociateVicePresident,
BhaswatS.Chakraborty,SeniorVP,R&D,
KavithaIyerRodrigues,Director,COO,
UnichemLaboratories
Cadila
TheramytNovobiologics
(https://www.linkedin.com/pub/v-k-sharma/23/ba/197)
(https://www.linkedin.com/pub/bhaswat-chakraborty/18/34/27)
(https://www.linkedin.com/pub/kavitha-iyer-rodrigues/b/b29/8b8)
MARKETOVERVIEW&ANALISYS
CHALLENGES&OPPORTUNITIES
RMP
12:40-Networking -Takeyourdiscussionsfurther&buildnewrelationshipsinarelaxed
&informalsetting...
luncheon
SPONSOR SITE CRO-PATIENTS
14:00-AfternoonKeynotePanelDiscussion-Maintainingproperbalanceinrelationships:Sponsor Site CRO&Patients
Moderator:
Panellists:
Four-wayrelationshipbetweensponsors,sites,CROs&patients-
Realisticexpectations,clearcommunications,shared
understandings,practicalpolicies,andefficientproblemresolution
Quantitativeanalysisrevealsrapidchangesintheindustryand
trendsforthefuture.Howcansponsors,sitesandCROsmeetthe
challenges?
Choosingapartnerwhocantakenecessarystepstorectifythes
ituationwhenthingsgowrong
Understandingsponsorsprincipleforselectingthelocalclinical
researchorganization
Identifyingtheanticipatedadvantagesofacollaborativeclinicaltrial
allianceforgreaterefficiencyandcostreduction
Whatarethecurrentperspectivesonthefutureofoutsourcingin
Asia?
AmitArora,HeadMedicalAffairs,
AshwaniPandita,HeadQualityManagementandTraining,GlobalClinicalResearchOperations,
SujaySalvi,Head,ClinicalTrialSuppliesManagement,
MerckSerono
Glenmark
SIROClinpharm
(https://www.linkedin.com/in/arora007)
(https://www.linkedin.com/pub/ashwani-pandita-rqap-gcp/14/997/590)
(https://www.linkedin.com/pub/sujay-salvi/5/73b/82a)
DAY1-28thMAY2015
6thAnnualClinicalTrialsSummit2015
28th&29thMay2015,KohinoorContinentalHotel,Mumbai,India
-
15:20 AfternoonTea/Coffee
15:40 Monitoring,managingandleadingclinicaltrials:Anintegratedapproachforbettertrialsuccess
Clinicalresearchstaffshouldunderstandthedifferencebetweentactileexecutionandstrategicexecutioninclinicaloperations
Itisimportanttogainnewinsightsintoanintegratedrolewhichaddressesmanyunmetneedsofaclinicaltrial
The'NextGenerationClinicalResearchProfessionals'shouldadapttotheirnewrolebylookinginsidetofacetheoutside
Clinicaltrialsuccessdependsgreatlyoncreatingandnourishingacollaborativeandlearningcultureinthisnewrole
16:50-Chairpersonsclosingremarksandendofconference
6thAnnualClinicalTrialsSummit2015
28th&29thMay2015,KohinoorContinentalHotel,Mumbai,India
14:40-PanelDiscussion-Marginofsafety:IdentifyingidealclinicalsitesandstrategizingpatientrecruitmentandclinicalsitesmanagementinIndiatodevelopappropriateclinicalstudies
Moderator:
Panellists:
Toimplementcorrectsafetyandhealthymeasures.
Ensuringsecurityofclinicaldataandnon-disclosure.
Challengesforqualityassuranceinclinicaltrials.
Usingpharmacovigilancedatabasestofacilitatethedetectionof
adverseeventsandthegenerationofsafetysignals
ExamininginformationprovidedinIndividualCaseSafetyReports
(ICSRs)todeterminewhetherasignalshouldbeinvestigatedor
not
Start-upteamstomanageclinicaltrials:advantagesand
limitations
DeeptiSanghavi,SeniorMedicalWriter-MedicalWriting,
ChiragTrivedi,Director&HeadofClinicalStudyUnit,
PratikShah,Head-Clinical,Medical&RegulatoryAffairs,PVandQA,
JyotsnaPatwardhar,HeadDevelopmentQA,
ChitraBargaje,Consultant,
SIROClinpharm
SanofiAventis
AstellasPharma
Novartis
ADAMASConsulting
(https://www.linkedin.com/pub/dr-deepti-sanghavi/5/591/b76)
(https://www.linkedin.com/pub/dr-chirag-trivedi/21/b0/344)
(https://www.linkedin.com/in/drpratikshah)
(https://www.linkedin.com/in/chitrabargaje)
QUALITY-SAFETY-SIGNALDETECTION Moderator:
Panellists:
MilindAntani,Head-PharmaLifeSciences,
K.Bangarurajan,Dy.DrugsController(I)CDSCO,
MazharMaruf,RegionalHeadofPharmacovigilance-AsiaPacific,
KedarSuvarnapathaki,Head-RegulatoryAffairs,
BabitaKirodian,HeadofCountryPharmacovigilance,
NishithDesaiAssociates
DCGI
Glenmark
BoehringerIngelheim
BristolMyersSquibb
(https://www.linkedin.com/in/milindantani)
(https://www.linkedin.com/pub/dr-mazhar-maruf/b/303/2b5)
(https://www.linkedin.com/pub/kedar-suvarnapathaki/4/954/765)
(https://www.linkedin.com/profile/view?id=37647503)
17:00-18:00-Networking -Takeyourdiscussionsfurther&buildnewrelationshipsina
relaxed&informalsetting...
Drinks
REGULATORY
16:10 PanelDiscussion:Thedevelopingregulatoryframeworkinadvancedanddevelopingmarkets forToday&Tomorrow
AdaptingtoIndiastransformedregulatorylandscapestoconduct
clinicaltrials
Abriefrecapofrecentregulatorydevelopments.Ensuringyou
complywithmarketrequirements
WhatistobelearntonhowIndiancompaniescanworkin
harmonywiththeRoWlegalframeworks
EffectivelyincorporatingGCP&GCPs KnowingwhatTO-DOand
whatNOTTO-DO
-
6thAnnualClinicalTrialsSummit2015
28th 29thMay2015,KohinoorContinentalHotel,Mumbai,India&
A2020VisionforClinicalResearchInIndia
WorkshopLeadersFrom
(TBC)
09:00-10:00Coffee&Registration
10:00-16:00Workshop
TimingIncludesLunchandRefreshmentBreaks
ABOUTVIRTUEINSIGHT-
VirtueInsightequipsbusinessprofessionalsaroundtheworldwiththelatest
indepthindustryknowledgeandprovidesnetworkingopportunitiesinthe
telecom,infrastructureandpharmaceuticalindustry.Ouraimistoprovidea
platformtoshareknowledgeandinsightandprovideoureventattendeesto
networkeffectivelyanddelivermaximumROIbymake
newbusinessalliances.Westrivetoproducehighqualityconferenceswhich
includethelatesttopicswhichare
deliveredbyworldclassleadersoftheindustry.
Ourmottoistoofferourcustomerstheexpertiseandconnectionsforaprofitable
business.OureventsencompassanoptimumchancetogainmaximumROIby
makingnewbusinessalliances.
FormoreInformation,visit: http://www.virtueinsight.com/
Tel:+9104464536444Visit: www.virtueinsight.com
WorkshopAgendaand
WorkshopLeaders
tobeAnnouncedShortly...
ABOUTMEDIDATA-
Weprovideinnovativeclinicaldevelopmentsolutionsthatsafelyand
efficientlyimprovequalityoflife.Weprovideourcustomerswitha
competitiveadvantagebyfacilitatingoperationalexcellenceintheir
clinicalresearchprocesses:
Eliminatingredundantanderror-proneprocesses,
Fosteringcollaborationviadynamicinformationflow
betweentraditionaltrialdesign,planning,execution
andanalysissilos
Increasingstudyexecutionagilitythroughinsightful
decision-making
Maximizingvaluetositesandsponsorsby
supportingabest-in-classsolutionapproach.
FormoreInformation,visit: http://www.mdsol.com/
DAY2-29thMAY2015
-
FLOORPLAN:- Bookyourstallsnowbeforetheyrunout!!!
1
2 5
3
4
CO
NF
ER
EN
CE
HA
LL
1
CO
NF
ER
EN
CE
HA
LL
2
CO
NF
ER
EN
CE
HA
LL
3
1
Coffee/Tea/NetworkingArea
POOL
SIDE AREA
NETWORKING
LUNCHEON
4
5
6
2
3
REGISTRATIONDESK
6
6thAnnualClinicalTrialsSummit2015
FLOORPLAN - Bookyourstallsnowbeforetheyrunout!!!
7
7
-
AttendeesfromourpreviousClinicalTrialsConferenceAbbott
AbbottNutritionR&D
Acceliant
Accutest
ACGAssociatedCapsules
Alcon-GlobalClinicalSite
Management
AlkemLaboratories
AllerganHealthcare
Antara
Apotex
AstellasPharma
AstraZeneca
AtharvaLifesciencesConsulting
BangaloreDiabetesHospital
Bayer
BeroeConsultingIndia
BioSpectrum
BiotechnologyIndustryResearch
AssistanceCouncil
BoehringerIngelheim
Bristol-MyersSquibb
BusinessVibes
C.L.A.I.M.S
Cadila
CambridgeResearch&
Instrumentation
CanBiotech
CCRT
Cipla
ClinicalDiagnosticCentre
Clinigene
Cliniminds
ClininventResearch
CliniSearch
ClinitrialsResearch
Clinnex
ClinOmaHealthcare
ClinTrialsResearch
CoffeeDay
CognizantTechnologies
CSC
CygnusBusinessonsulting&research
DaburIndia
DBMSConsulting
DCGI
DiagnoSearchLifeSciences
Dr.Reddy'sLaboratories
ECCROIndiaServices
EcronAcunova
EliLilly
ExpressPharma
FamyCare
ForteResearchSystems
FortisClinicalResearch
FreseniusKabi
G7SYNERGON
GenericLicensing
GlaxoSmithKline
Glenmark
GlobalData
GlobalHealth
GoingToMeet
GVKBio
HCLTechnologies
HeartCareAssociates
HindujaHospital
HindustanTimes
HospiraHealthcare
ICRI
ImageCoreLab
InbioproSolutions
IndianAcademyofClinicalResearch
IndusBiotech
InventBioMed
ITS-DCHRC
JAICAsiaHoldings
JameJamshedWeekly
JHBio
JohnsonandJohnson
JubilantClinsys
KarmicLifesciences
LambdaResearch
LinkpingUniversity
LupinBioresearchCenter
Marken
MediStatsLab
MetropolisHealthcare
MMSHClinicalResearch
MSClinicalResearch
Newtronic
NishithDesaiAssociates
Novartis
NovartisHealthcare-VaccinesDivision
OcasaLogisticSolutions
OmniActiveHealthTechnologies
OncquestLaboratories
OviyaMedSafe
PanaceaBiotec
ParadigmIT
Percipenz
PharmaBioWorld
PharmaMirror
PharmaLeaf
PharmaVOICE
Pharmcast
PiramalLifeSciences
PRAInternationl
ProvenanceResearch
QuadOneTechnologies
Quartesian
QuestDiagnostics
Quintiles
RegPakBioPharmaConsulting
RelianceLifeSciences
RubiconResearch
RubyHallClinic
SPSoftwareTechnologies
SanofiPasteur
SanofiPasteur
Sanofi-Aventis
SenceCR
SerumInstituteofIndia
SGDS.AGlass
SIROClinpharm
SolonistBusinessSolutions
SPSoftwareTechnologies
SRL
SRLDiagnostics
StempeuticsResearch
Strides
TCS
TechObserver
TechTree
TechsolSystems
Templegate
ThePharmaWorld
TorrentResearchCentre
U.S.Embassy
Unilever
Unithink
UntilRoi
VAC3ClinicalService
Vanthys
VeedaClincialResearch
VerGoPharmaResearch
VoisinConsulting
VoisinLifeSciences
VPH
WatsonPharma
WesternInstitutionalReviewBoard
Witness
Wockhardt
WorldPharmaToday
YCLIN
ZydusCadilaHealthcare
A.Menarini
Abbott
AbbottNutritionR&D
Acceliant
Accutest
ACGAssociatedCapsules
ACMGlobalCentralLaboratory
AETLaboratories
Alcon-GlobalClinicalSite
Management
AlkemLaboratories
AllerganHealthcare
Antara
Apotex
AstellasPharma
AstraZeneca
AtharvaLifesciencesConsulting
AurigaResearch
AurigeneDiscoveryTechnologies
AzidusLaboratories
BangaloreDiabetesHospital
Baxter
Bayer
BeroeConsultingIndia
Bilcare
BioconFoundation
BioSpectrum
BiotechnologyIndustryResearch
AssistanceCouncil
BoehringerIngelheim
Bristol-MyersSquibb
BusinessVibes
C.L.A.I.M.S
Cadila
CambridgeResearch&
Instrumentation
CanBiotech
CCRT
Cipla
CityXRay&ScanClinic
ClinicalDiagnosticCentre
Clinigene
Cliniminds
ClininventResearch
CliniSearch
ClinitrialsResearch
Clinnex
ClinOmaHealthcare
ClinTrialsResearch
CoffeeDay
CognizantTechnologies
CrescentScientific
CSC
CygnusBusinessonsulting&research
CytespaceResearch
DaburIndia
DBMSConsulting
DCGI
DiagnoSearchLifeSciences
Dr.Reddy'sLaboratories
ECCROIndiaServices
EcronAcunova
EliLilly
EMCCorporation
EtykaClinicalSolutions
ExpireHealthResearch
ExpressPharma
FamyCare
ForteResearchSystems
FortisClinicalResearch
FreseniusKabi
G7SYNERGON
GenericLicensing
GlaxoSmithKline
GlenmarkPharmaceuticals
GlobalData
GlobalHealth
GoingToMeet
GovernmentofVictoria,Australia\
Indiaoffice
GSK
GVKBio
HCLTechnologies
HeartCareAssociates
HindujaHospital
HindustanTimes
HospiraHealthcare
ICRI
ImageCoreLab
InbioproSolutions
INCResearch
IndiaLaw
IndianAcademyofClinicalResearch
IndusBiotech
Interveinlaboratories
InventBioMed
ITS-DCHRC
JAICAsiaHoldings
JameJamshedWeekly
JHBio
JohnsonandJohnson
JubilantClinsys
KAPComputerSolutions
KarmicLifesciences
LambdaTherapeuticResearch
LinkopingUniversity
LotusLabs
LupinBioresearchCenter
Marken
MedantaDukeResearchInstitute
MediStatsLab
MedidataSolutions
MetropolisHealthcare
MetropolisHealthcare
MJBiopharm
MMSHClinicalResearch
MSClinicalResearch
MylanLaboratories
NatcoPharma
NationalInstituteofHealth,U.S.
Embassy
Newtronic
NishithDesaiAssociates
Novartis
OcasaLogisticSolutions
OmniActiveHealthTechnologies
OncquestLaboratories
OracleHealthScience
OviyaMedSafe
PanaceaBiotec
ParadigmIT
PDPCouriers
Percipenz
Pfizer
PharmaBioWorld
PharmaMirror
PharmaLeaf
Pharmaphorum
PharmaVOICE
Pharmcast
PhysisLearningAcademy
PiramalLifeSciences
PirmalHealthcare
PRAInternationl
ProvenanceResearch
QuadOneTechnologies
Quartesian
QuestDiagnostics
Quintiles
RanbaxyLaboratories
RegPakBioPharmaConsulting
RelianceLifeSciences
RubiconResearch
RubyHallClinic
SPSoftwareTechnologies
SahajanandMedicalTechnologies
SalzerTechnologiesLimited
SanofiAventis
SanofiIndia
SanofiPasteur
Sanofi
SciformixTechnologies
SenceCR
SerumInstituteofIndia
SFSPharmaLogistics
SGDS.AGlass
ShanthaASanofiCompany
SIROClinpharm
SolonistBusinessSolutions
SPSoftwareTechnologies
SpectrumOncology
SRLDiagnostics
StempeuticsResearch
Strides
SunPharmaAdvancedResearch
Company
TataMemorialHospital
TCS
TechObserver
TechTree
Tech-Observer
TechsolSystems
Templegate
ThePharmaWorld
TorrentResearchCentre
U.S.Embassy
Unilever
Unithink
UntilRoi
VAC3ClinicalService
Vanthys
VeedaClincialResearch
VerGoPharmaResearch
VoisinConsulting
VoisinLifeSciences
VPH
WatsonPharma
WesternInstitutionalReviewBoard
Witness
Wockhardt
-
RegistrationForm
28th&29thMay2015,KohinoorContinentalHotel,Mumbai,India
Queries:
GeneralinformationVenue:
Paymentterms:
Substitutions/namechangesorcancellations:
Indemnity:
Fee:
Howwewillcontactyou:
Shouldyouhaveanyquestionsonbookings,
Pleasefeelfreetocontactus.
Email:
Web:
IndiaOffice:Tel:+9104464536444
KohinoorContinentalHotel
AndheriKurlaRoad
Andheri(E)
Mumbai400059-India
Tel:912266919000/912228209999
VirtueInsightrequiresthefullamounttobepaidbeforethe
conference.VirtueInsightmayrefuseentrytodelegateswhohave
notpaidtheirinvoiceinfull.
Thereisa50%liabilityonallbookingsoncemade,whetherbypost,
fax,oremail.Thereisanorefundpolicyforcancellationsreceived
onorafteronemonthbeforethestartoftheevent.Shouldyoudecide
tocancelafterthisdate,thefullinvoicemustbepaid.Conference
noteswillthenbesenttoyou.Unfortunately,weareunabletotransfer
placesbetweenconferencesandexecutivebriefings.However,ifyou
cannotattendtheconference,youmaymakeasubstitution/name
changeatanytime,aslongasweareinformedinwritingbyemail,
faxorpost.Namechangesandsubstitutionsmustbefromthesame
companyororganizationandarenottransferablebetweencountries.
VirtueInsightreservestherighttomakealterationstothe
conference/executivebriefingcontent,timing,speakersorvenue
withoutnotice.Theeventmaybepostponedorcancelleddueto
unforeseeneventsbeyondthecontrolofVirtueInsight.Ifsucha
situationarises,wewillrefundyourregistrationfeeandwewilltry
torescheduletheevent.
Theconferencefeeincludeslunch,refreshmentsandconferencepapers
providedontheday.Thisfeedoesnotincludetravelorhotel
accommodation.
VirtueInsight'spreferredmethodofcommunicationisbyemailand
phone.Pleaseensurethatyoucompletetheregistrationforminfull
sothatwecancontactyou.
http://www.virtueinsight.com
NewsUpdates:
Pleasetickifyoudonotwishtoreceiveemailupdatesin
thefuture
www.virtueinsight.com
EarlyBirdDiscount
Book&paybefore12th April2015
RESERVATIONPRICING:
REGISTRATIONFORMDETAILS:
Conference&Workshopperdelegate-Fee:INR06,000+Tax
C
-Fee:INR07,000+Tax
Forename............................Surname................................
JobTitle..............................Company................................
OfficialContactNumber.......................................................
Address.............................................................................
.............................................................................
Country...............................Postcode..................................
Phone..................................Fax........................................
Email.................................................................................
IconfirmthatIhaveread&agreetothe
termsandconditionsofbooking.....(PleaseTick)
Signature...........................................................................
Completeandreturntheaboveregistrationformvia
postoremail,togetherwithyourchequepayabletoVirtueInsight.
VirtueInsight
830092431
IDIB000V080
IndianBank
118-119,IndiraNagar,Valasaravakkam,
Chennai600087,Tiruvallurdistrict,TamilNadu,India
EarlyBirdDiscountRateTill17thApril2015
StandardRate-Applicableafter17thApril2015
MethodsofPayments:
ByCheque-
ByBankTransfer:
AccountName-AccountNumber-SortCode-BankAddress-
(PleaseTick)
(PleaseTick)
(PleaseTick)
onferenceonly-Fee:INR05,000+Tax
Conference&Workshopfor1or2delegates/D
Conferenceonlyfor1or2delegates/D-Fee:INR06,000+Tax
Conference&Workshop-3&abovedelegates-/D-Fee:INR06,000+Tax
ConferenceOnly-3&abovedelegates-/D-Fee:INR05,000+Tax
2Daysconference&Workshop/D-Fee:INR08,000+Tax
GroupBookings
SpotRegistration:-